Study to Intervene With Nutrition for Gastroparesis
NCT03987672 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2022-08-22
Summary
The study is a self-controlled study in which we will assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula in patients with gastroparesis, relative to their pre-enrollment nutritional diet regimen.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula
Kate Farm Peptide 1.5 nutritional Formula
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Linda Anh Nguyen, MD · Stanford University
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-01
- Primary Completion
- 2022-08-18
- Completion
- 2022-08-18
Countries
- United States
Study Locations
More Related Trials
-
Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia
NCT05055336 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis
NCT04869670 ·Status: TERMINATED ·Phase: NA
-
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
NCT04661215 ·Status: RECRUITING
-
Gastric Emptying: in Vivo Studies in Healthy Volunteers
NCT02994472 ·Status: UNKNOWN ·Phase: NA
-
G-POEM vs PEG-J in Gastroparesis Patients
NCT06372132 ·Status: RECRUITING ·Phase: NA
-
Body Surface Gastric Mapping Vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis
NCT06411574 ·Status: RECRUITING ·Phase: NA
-
Washed Microbiota Transplantation Combined with Enteral Nutrition for Gastroptosis
NCT06837194 ·Status: RECRUITING
-
Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial
NCT06173336 ·Status: WITHDRAWN ·Phase: NA
-
Gastroparesis Registry 3
NCT03680859 ·Status: COMPLETED
-
A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time
NCT00128284 ·Status: COMPLETED
-
Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis
NCT02022826 ·Status: TERMINATED ·Phase: NA
-
Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis
NCT07324785 ·Status: RECRUITING
-
Haloperidol vs Conventional Therapy for Gastroparesis
NCT02057549 ·Status: TERMINATED ·Phase: PHASE4
-
GI Tolerance and Acceptability of a New Thickener
NCT04104815 ·Status: WITHDRAWN ·Phase: NA
-
Open-Label Placebo for Functional Dyspepsia
NCT03745781 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Idiopathic Esophagogastric Junction Outflow Obstruction
NCT04096703 ·Status: WITHDRAWN ·Phase: NA
-
Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification
NCT01173484 ·Status: TERMINATED
-
IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the Stomach
NCT01858220 ·Status: UNKNOWN
-
Evaluation of Food Hypersensitivity in Children/Adolescents With Functional Dyspepsia
NCT00328679 ·Status: COMPLETED ·Phase: PHASE1
-
Endoscopic Full Thickness Biopsy, Gastric Wall.
NCT01650714 ·Status: COMPLETED ·Phase: NA
-
Carbon-13 (13C)-Spirulina Platensis Gastric Emptying Breath Test (GEBT)
NCT01248221 ·Status: COMPLETED ·Phase: NA
-
Gastroparesis Registry
NCT00398801 ·Status: COMPLETED
-
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
NCT02875678 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Motilitone to Treat Functional Dyspepsia
NCT02365701 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
NCT07152756 ·Status: NOT_YET_RECRUITING